Treatment of AML cells from healthy control individuals with infliximab decreased the levels of both O2− and H2O2 produced in response to stimulation with PMA or PMA plus IFNγ, suggesting that TNF signalling is crucial for ROS production by AML cells in vitro (Fig. 4c–f). The gene discussed is IFNG; the disease is acute myeloid leukemia.